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Abstract: Three new silica-based glass formulations with low molar Ca/P ratio (2–3) have been
synthesized. The thermal properties, the crystalline phases induced by thermal treatments and
the sintering ability of each glass formulation have been investigated by simultaneous differential
scanning calorimetry-thermogravimetric analysis (DSC-TG), X-ray diffraction (XRD) and hot stage
microscopy (HSM). The glasses exhibited a good sintering behavior, with two samples achieving
shrinkage of 85%–95% prior to crystallization. The bioactivity of the glasses in simulated body fluid
(SBF) has been investigated by performing XRD and Fourier transform infrared spectroscopy (FTIR)
on the samples prior and after immersion. The glasses with lower MgO contents were able to form
a fully crystallized apatite layer after three days of immersion in simulated body fluid (SBF), while for
the glass exhibiting a higher MgO content in its composition, the crystallization of the Ca–P layer was
achieved after seven days. The conjugation of these properties opens new insights on the synthesis of
highly bioactive and mechanically strong prosthetic materials.
Keywords: bioactive glasses; bioactivity; Ca/P ratio; densification; sintering
1. Introduction
Tissue engineering has emerged as a promising approach for repair and regeneration of tissues
and organs, lost or damaged as result of trauma, injury, disease or aging [1]. For many years,
autografts, allografts and xenografts have been used as prosthetic materials in the field of tissue
engineering [2]. However, most of these implants suffer from problems of interfacial stability with
host tissues, biomechanical mismatch of elastic moduli, production of wear debris and maintenance of
blood pressure, immune rejection or viral transmission from the donor [2,3]. To overcome many of
these problems, in the last few years, synthetic grafts as hydroxyapatite, tricalcium phosphate and
bioactive glass and glass-ceramics have been highly investigated, focusing attention on their ability to
bond to the surrounding osseous tissue and to enhance bone formation [4]. In the case of bioactive
glasses, it has already been demonstrated that the mechanism of bonding to living tissues involves
11 reaction steps [5]. In this cascade of reactions, the first five steps occur essentially on the glass surface
and involve rapid ion exchange of Na+ with H3O+, followed by the formation of surface silanols, that
undergo polycondensation creating a silica gel layer which, in turn, provide a high number of active
sites for heterogeneous nucleation and crystallization of a biologically reactive hydroxy-carbonate
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apatite layer. Due to its high similarity to the inorganic mineral phase of bone, this layer provides
an ideal environment for colonization of osteoblasts, proliferation and differentiation of the cells to
form new bone, creating a mechanically strong bond with the implant surface [5]. According to Hench,
glasses having <60 mol % SiO2 in their composition, high CaO and Na2O contents and high Ca/P ratio
are bioactive [6], whereas glasses with much lower Ca/P ratio would not bind to bone [7]. These rules
were well expressed on the formulation of the one of the most popular bioactive glasses, the 45S5
(Bioglass®), whose composition (wt %) is 45% SiO2, 24.5% CaO, 6% P2O5 and 24.5% Na2O, having
a molar Ca/P ratio of 5. Other Bioglass®-based compositions, having a fixed amount of P2O5 were
developed, including the 52S4.6 and 55S4.3 [8], KGS Ceravital [9], S45P7 [10] and, more recently, the
glass S53P4 [11]. Although all these glasses exhibited a good bioactivity, and some of them reached
commercial success, they have some limitations in terms of their physico-chemical properties, mainly
due to their deficient thermal behavior that provides a negative impact on their sintering ability
and mechanical properties, limiting the application of these glasses as powder and granule bone
fillers rather than 3D load bearing implants [12,13]. In this context, a series of glasses in the system
CaO-MgO-SiO2-Na2O-P2O5-CaF2 exhibiting good sintering properties in a temperature range below
crystallization were developed [14,15]. Other glasses in this system exhibiting good bioactivity include
the AP40 [16], 13-93 [17] and CEL2 [18]. A common feature of all these glasses is the amount of P2O5,
which covers a concentration range between 4 and 11 wt % and a Ca/P > 4. Very little work has been
done on designing formulations having high amounts of P2O5, or lower Ca/P ratio. One of the few
studies performed in this field revealed that glasses in the system SiO2-CaO-P2O5-Na2O containing
10 wt % P2O5 exhibited good mechanical properties (bending strength between 120 and 190 MPa
and compressive strength 600–900 MPa), which is considerably higher than the one observed for
45S5 glass-ceramics compacts (bending strength 30 MPa and compressive strength 37 MPa) [19].
Besides their biocompatibility, these low Ca/P glasses were able to form a tight chemical bond with
bone [20–22]. In terms of bioactivity, it is generally well established that glasses having a high amount
of P2O5 in their composition exhibit a high polymerization of the silicate network, which in turn has
a negative impact on glass bioactivity [23–25]. However, one of the few studies on the influence of
P2O5 content on the bioactivity of glasses in the system SiO2-CaO-P2O5-Na2O suggests that although
the glass network connectivity increases, an increase in the rate of formation of the apatite layer may be
also observed in glasses with a high amount of P2O5 (~10 wt %) [26]. In this study, glasses with 6.8 wt %
P2O5 content were found to form a crystallized apatite layer after 16 h of immersion in SBF solution,
exhibiting intense, narrow and split peaks on the zone of 550 cm´1, detected by FTIR, whereas for 45S5
bioglass, the phosphate peak could hardly be resolved from the background after 1 day immersion.
Some studies regarding the SiO2 and MgO content of bioactive glasses were also published [27,28].
While Oliveira et al. [27] studied the role of MgO on the surface reactivity of glasses belonging to the
SiO2-P2O5-CaO-MgO system, reporting an increasing surface activity with increasing MgO/CaO ratio,
Verné et al. [28] have prepared and characterized a set of glasses and glass-ceramics belonging to the
SiO2-P2O5-CaO-MgO-K2O-Na2O system, reporting very low influence of the MgO/CaO ratio on the
bioactivity mechanism. These observations open a new way towards the rational design of glasses
with high bioactivity and guides to a new interpretation of their composition-structure relationship.
In recent years, the inclusion of CaF2 in bioactive glass formulations has also attracted great interest
due to the possibility of formation of a fluoroapatite crystalline phase [29]. Fluoroapatite has a higher
chemical stability than hydroxyapatite and is determinant in the prevention of caries [30]. Furthermore,
fluorine is well known to prevent dental decay by inhibiting enamel and dentine demineralization,
enhancement of remineralization and inhibition of bacterial enzymes [31].
Herein, we present the design and development of three new bioactive glass formulations in the
system SiO2-CaO-P2O5-Na2O-K2O-MgO-CaF2 with low CaO/P2O5 ratio, and different MgO/CaO
ratio. These new formulations belong to the system of the apatite-wollastonite glass-ceramics, which
have high potential as mechanically strong prosthetic implants [27,28]. The thermal behavior and
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bioactivity of the newly developed glasses as well as the effect of MgO/CaO ratio on these parameters
were investigated.
2. Results and Discussion
Three new glass formulations in the system SiO2-P2O5-CaO-Na2O-MgO-CaF2 having a low molar
Ca/P ratio (2.3–2.8) were developed and their physico-chemical properties investigated, regarding
their possible application as prosthetic materials.
As represented in Table 1, a common characteristic between these new glass formulations is
related with their high P2O5 amount (14–17 wt %), which highly influences the physico-chemical
properties of the material [20,21]. Taking into account this feature, the thermal properties of the newly
developed glasses were investigated using DSC-TG and HSM. As glass B32 was developed from glass
B31 by substitution of CaO with MgO, the resultant DSC and HSM curves were combined in the same
graph to allow a better analysis on the influence of this substitution in the thermal behavior of the glasses.
Table 1. Formulations of the newly developed glasses.
Glass
Composition (wt %)
Ca/P Molar Ratio
SiO2 P2O5 CaO Na2O K2O MgO CaF2
B4 40.4 17.0 30.0 7.0 0.3 4.0 1.3 2.3
B31 40.0 14.0 30.0 10.5 0.5 3.0 2.0 2.8
B32 40.0 14.0 28.0 10.5 0.5 5.0 2.0 2.7
Figure 1B shows that the newly developed glasses B31 and B32 exhibit a single-stage shrinkage
and a good sintering behavior, this last one supported by their high densification degree prior to the
onset of crystallization. The data provided by Figure 1 are summarized in Table 2.
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between the temperature of onset of crystallization and temperature of maximum shrinkage, may be 
related with the higher amount of P2O5 present in this glass formulation, which often guides to an 
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Figure 1. DSC (I) and HSM (II) curves f 4 (A), B31 and B32 (B). Tg: Temperatu e glass transition;
Tc: onset of crystallization; Tp1–Tp3: Maximum temperatures of crystallization; TFS: Temperature first
shrinkage; TMS: Temperature maximum shrinkage.
Table 2. Thermal parameters obtained from the DSC-TG/HSM analysis. Tp: Maximum crystallization
temperature; STAB: Stability (Tc-Tg); Tg: Glass transition; TFS: Temperature first shrinkage;
TMS: Temperature maximum shrinkage; Shrink, Shrinkage; Tc: onset of crystallization; Sc: Sintering
abil ty (Tc-TMS). The temperature values are expressed i ˝C.
Glass Tp1 Tp2 Tp3 Tg STAB TFS TMS ∆T1 Shrink1(%)
Shrink until
Tc (%)
Shrink2
(%)
Shrink
Total (%) Tc Sc
B4 731 832 993 662 69 680 730 50 9.25 5.55 3.73 13.7 715 ´15
B31 770 815 1020 623 117 650 730 80 16.55 16.55 2.76 19.31 740 10
B32 762 812 1036 620 107 640 730 90 18.06 18.06 1.42 19.48 727 ´3
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According to HSM analysis of glasses B31 and B32 (Figure 1B, curve II), 86% and 93%, respectively,
of the total densification (19.3% and 19.5%) exhibited by these glasses was achieved below the Tc.
Such behavior is nowadays considered an essential characteristic for the production of viscous flow
sintered scaffolds with high mechanical properties [15]. The glass B4 exhibited the worst sintering
behavior, presenting a two-stage densification and shrinkage of 9.25% (out of 13.7%) around the onset
of crystallization (Tc). This lower sintering ability (Sc = ´15), represented as the difference between
the temperature of onset of crystallization and temperature of maximum shrinkage, may be related
with the higher amount of P2O5 present in this glass formulation, which often guides to an increase
on the extent of polymerization of the silicate glass network, resulting in the reinforcement of the
glass structure [6]. Consequently, the temperature required to promote the densification of the glass
is usually higher, guiding to a natural decay in glass shrinkage and, consequently, in its sintering
performance. The characteristic viscosity points of the synthesized glasses were determined by DSC.
By analyzing Figure 1A curve I and Figure 1B curve I, it can be observed that Tg was higher for glass
B4 (662 ˝C), containing the highest amount of P2O5, in comparison with glasses B31 (620 ˝C) and B32
(616 ˝C). Although this could arise from a possible higher network connectivity of glass B4, it cannot
be ruled out that it is due to the lower wt % of CaF2 in the glass formulation. It has been already
studied that CaF+ species form weak electrostatic forces between the non-bridging oxygens of the
glass network (similar to the ones of the fluxing agents), decreasing the bonding strength between
the silicate ions in the network and consequently, the temperature required for the glass to lose its
cohesiveness [32,33]. Furthermore, the high similarity between the ionic radius of fluorine (1.36 Å) and
the one of the oxygen (1.40 Å) may guide to the replacement of bridging oxygens with non-bridging
fluorides, resulting in the disruption of the glass network [30,34]. As a result, glass B31 and B32,
both having a higher amount of CaF2, would benefit of a lower Tg, as demonstrated in Figure 1B.
The obtained DSC data (Figure 1A curve I and 1B curve I) show that all the glasses present a similar
crystallization behavior, exhibiting three main crystallization peaks. However, considering that the
presence of CaF+ species softens the glass network, it would not be expected that glasses B31 and B32
have higher Tp1 temperatures than glass B4. To discuss this behavior, another subject has to be brought
into account, which is the increase in the Ca/P ratio of the glass as CaF2 increases. It is already known
that fluorapatite undergoes phase separation below crystallization [35]. Thus, glasses with higher
amount of P2O5 (as glass B4) would present a lower activation energy for the nucleation of fluorapatite,
as the addition of P2O5 induces phase separation in the glass network. This phenomenon facilitates the
growth of fluorapatite crystals due to an enriched composition of the phase in the components of this
mineral, specifically P5+ and Ca2+, guiding to a lower Tc and Tp1. On the other side, the higher amount
of CaF2 present in the composition of glasses B31 and B32 induces the formation of a higher number of
nuclei per volume of glass, in comparison with sample B4. Consequently, the network connectivity
of the glass surrounding the nucleus will be higher, creating a barrier to crystal growth and thus,
guiding to an increase in the activation energy required for the crystallization of fluorapatite [36].
Thus, it is reasonable that a lower Tp1 is observed in the glass with the higher P2O5 content and lower
CaF2 composition. The crystalline phases nucleated at Tp1, Tp2 and Tp3 on the three glasses were
investigated by XRD (Figure 2).
The results obtained in Figure 2 are summarized in Table 3 for a better comparison of the crystalline
phases found on the three glasses.
XRD analysis of the crystallized samples allowed us to conclude that the apatite phase Ca5(PO4)3(OH, F)
was present in all the glass-ceramics (PCPDF 98-007-7966). While on the glass with the highest
P2O5 content this was the only crystalline phase present at Tp1, in B31 and B32 glasses devitrite
(Na2Ca3Si6O16; PCPDF 98-007-7397) crystals grew along with the apatite phase. As observed
in Table 3, there is a clear trend for the precipitation of calcium-rich crystalline phases, such as
diopside (MgCaSi2O6; PCPDF 98-002-1772), wollastonite (CaSiO3; PCPDF 98-002-1772) or devitrite
(Na2Ca3Si6O16; PCPDF 98-004-6279) as the content in P2O5 decreases. This was rather expected, since
the higher amount of non-bonding oxygens in the glasses B31 and B32, arising from a potentially
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lower network polymerization, favors the formation of crystalline phases containing modifiers (CaO,
CaF2, MgO) and/or fluxing agents (Na2O, K2O). These calcium-silicate phases were detected in glass
B4 at temperatures around 1000 ˝C, due to a higher resistance of the glass network to deformation,
which is also in accordance with the HSM results (Figure 1II). In glass B32 at Tp2, the effect of replacing
CaO by MgO favored the formation of a magnesium-calcium silicate crystalline phase (diopside)
instead of wollastonite (B31). The obtained data suggest that by adjusting the Ca/P ratio, a control
over the crystalline phase composition and bioactivity can be achieved. In order to get conclusions on
the influence of the glass composition and Ca/P ratio in its bioactivity, without having the interference
of such crystalline phases, the apatite forming ability of the glasses was investigated using amorphous
powdered glass compacts, sintered at a temperature below crystallization. The good sintering behavior
of the glasses allowed the preparation, at low temperatures, of sintered glass pellets that could be
easily manipulated.
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Figure 2. (I) Bioglass B4 crystallized at: A, 731 ˝C; B, 832 ˝C; and C, 993 ˝C for 1 h (β = 5 ˝C¨min´1).
(II,III) Bioglass B31 (II) and B32 (III) crystallized at: A, 765 ˝C; B, 814 ˝C; and C, 1020 ˝C for 1 h
(β = 5 ˝C¨min´1). XRD: Apatite (), Diopside (N), Wollastonite ( ), and Devitrite ().
Table 3. Crystalline Phases of the synthesized bioglasses B4, B31 and B32. Tp: Crystallization peak.
Glass Tp1 Tp2 Tp3
B4 Apatite – Apatite, Wollastonite, Diopside
B31 Apatite, Devitrite Wollastonite, Apatite, Devitrite Wollastonite, Apatite
B32 Devitrite, Apatite D vitrite, Diopside, Apatite Diopside, Wollastonite, Apatit
At this stage, it is useful to remember the mechanism of formation of the hydroxyapatite-like
layer on the surface of the bioactive glasses, which firstly occurs by release of Ca2+, Mg2+, and Na+
ions into SBF solution via an exchange with H+ ions present in the fluid (stage 1), followed by the
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formation of surface silanols, which in turn undergo polycondensation resulting in the formation
of silica gel layer on the glass surface (stage 2). This layer immediately combine with Ca2+ ions in
the fluid to form an amorphous calcium silicate layer (stage 3), which reacts with phosphate ions
present in SBF guiding to the formation of an amorphous calcium-phosphate layer with low Ca/P
ratio (stage 4). This phase later transforms into bone-like apatite crystal (stage 5), increasing its Ca/P
ratio and incorporating minor ions such as Na+, Mg2+ and Cl´ [1,37]. SEM analysis performed on
the glass surface after one day of soaking in SBF revealed that the glass having the lowest Ca/P ratio
exhibited a higher appetence for precipitation of calcium phosphate crystals (Figure 3).
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Figure 3. SEM-EDS on glasses: B4 ( – ); B31 ( –F); and B32 (G–I) after one day of soaking in SBF.
Magnification is 500ˆ (left) and 5000ˆ ( iddle). EDS analysis was done on the whole area of images
at 500ˆ. Samples were coated with Au.
SEM pictures of B4 at 5000ˆ magnification showed the presence of calcium phosphate crystals
covering all the surface of the glass just after one day of soaking in SBF. By analyzing the surface of
the other two glasses (B31 and B32), it seems that these kind of crystals are also present on them, but
in lower amount. This was confirmed by EDS analysis where the lowest Si/P and Si/Ca ratio was
detected for the surface layer on B4. Such results suggest that a Ca–P layer with higher thickness was
able to form on the surface of B4, highlighting its higher apatite forming ability when compared with
glasses B31 and B32. This behavior is in contrast with the theory established by Hench on the design
of bioactive glasses, wh c suggested tha glasses aving Ca/P ratio < 5, as the popular 45S5, would
not be able to form a tight bond to bone through the formation of an apatite layer [7]. A similar trend
in bioactivity was maintained a ter three days soak in SBF solution (Figure 4).
The higher amount of surf ce cracks (after drying the sample at 100 ˝C) observ d on sample B4,
characteristic of the growth of a silica gel layer on the first stages of bioactivity, is also evidence of the
higher bioactivity of this sample. Comparing glasses B31 and B32, the apparently lower Si/P observed
in the last suggests the presence of a calcium phosphate layer with higher thickness after three days of
soaking in SBF solution, which could be linked to a higher bioactivity.
SEM-EDS results revealed that after seven-day immersion in SBF, the surface layer of glass B4 still
exhibits a Ca:P 1:1, while the one present in glass B32 shows a Ca/P > 1, suggesting the formation of the
calcium deficient apatite on the first (Figure 5). The higher P2O5 content of B4 explains this behavior.
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in calcium. At this stage, however, due to the low Si/P ratio observed, all the glasses were already
covered by a considerable amount of Ca-P layer. The phase composition of the surface layer on the
glasses was also followed by XRD in order to obtain information about the identity of the layer and on
its amorphous/crystalline state (Figure 6).
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The obtained XRD patterns (Figure 6) confirmed the formation of a crystalline layer on the surface
of all the investigated glasses after a maximum of seven days immersion in SBF, which could be
identified as an apatite-like layer (PCPDF 98-007-7966). In glass B4, the position of the broad band
near 2θ = 32˝, where the most intense peak of hydroxyapatite usually appears, may suggest that
this layer could be partially crystallized just after one day of soaking in SBF solution (Figure 6IA).
However, a clearly crystalline state of this layer was observed after immersion of the B4 for three days,
where an additional peak appears around 2θ = 25˝, together with a broad signal between 2θ = 45˝–55˝
(Figure 6IB). From 3 to 21 days of immersion in SBF solution, it was observed an increase in the
crystallinity of the apatite layer, supported by the presence of characteristic hydroxyapatite peaks
in the range 2θ = 45˝ to 55˝. Although a similar behavior could be ob erved for glass B31, in the
sample B32 the crystalliza ion of this layer was only observed on samples so ked f r seven d ys in
SBF solution, suggesting that the substitution of CaO by MgO de ays the crystallization of the Ca-P
layer. Additional peaks around 2θ = 32 a d 45˝ observed on samples B31-1D (Figure 6IIA) and B32-3D
(Figure 7IIIB) indicate the presence of NaCl (PCPDF 98-002-2556) arising from the SBF. Characteristic
peaks of NaCl are also present in sample B31-3D (Figure 6IIB), but the shift of this peak to higher 2θ
values, together with its broader appearance suggest that a crystalline apatite layer is also present,
which is confirmed by the peak observed at 2θ = 25˝ in this same sample. In an attempt to obtain
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additional information on the rate of formation of the Ca-P layer, the surface of samples B4, B31 and
B32 after soaking in SBF solution were analyzed by FTIR (Figure 7).
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Focusing on the zone corresponding to lower wavelengths (400–610 cm´1) on native glass
samples (Figure 7A), it was possible to identify peaks associated with Si-O-Si rocking and PO4
bending vibrations [38]. While in sample B4 these peaks appear at 496 and 574 cm´1, respectively,
in the remaining glasses, they are positioned at higher wavelengths, 504 and 602 cm´1 (B31) and
505–606 cm´1 (B32). Such red-shifting of the PO4 bending vibrations in glass B4 may be related to
a depolymerization of the phase-separated phosphate network [39]. It has already been reported that
upon addition of P2O5, the P coordination in the phosphate network may be dominated by Q0 or
Q1 units [40]. The high frequency bands (>800 cm´1), corresponding to silicon-oxygen stretching
vibrations of silicate tetrahedron units, may also provide an idea on the degree of polymerization of
the silicate glass network [14]. In the three glasses, the presence of intense peaks around 940 cm´1
and 1030 cm´1, characteristic of Si–O´ stretching vibrations, suggest that the silicate glass structure
is dominated by the presence of Q3 and Q2 tetrahedral units [24,25]. Additionally, the presence of
a peak at 738 cm´1 confirms the predominance of these units [41]. It is well established that the highest
bioactivity from a phosphosilicate glass can be expected if Qn (Si) units, where n is the number of
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bonding oxygens (BO), are dominated by chains of Q2 metasilicates which are occasionally crosslinked
through Q3 units, whereas Q1 units terminate the chains [24]. Thus, the relatively disrupted silicate
network structure of these glasses is also on the basis of their high bioactivity. The presence of
non-bonding oxygens in glass structure facilitates the leaching of Ca2+ and Na+ ions, favoring the
formation of a bioactive layer on the glass surface.
After soaking in SBF for one day, some changes in the surface of the glasses have been observed
due to the appearance of new peaks in the range 1400–1500 cm´1, suggesting the precipitation of
carbonated species from the SBF [42]. The changes in the FTIR spectra were accentuated in samples
B4 and B31 after soaking for three days immersion in SBF, where a split of the peak at 572 cm´1
into two peaks positioned at 574 and 608 cm´1 could be observed (Figure 7IC,IIC). This result is
usually attributed to the formation of a crystallized apatite layer on the glass surface, indicating
that the last stage of bioactivity (stage 5) has been achieved [41]. The absence of these peaks after
soaking sample B32 for a similar period of time confirms the lower apatite forming ability of this
glass, which is in accordance with the obtained XRD results (Figure 6IIIB). The lower ratio between
the peaks at 1055 cm´1 (PO43´ asym stretching) and 940 cm´1 (Si–OH stretching) on glass B32 in
comparison with glass B31 during all the bioactivity experiment also supports the lower apatite
forming ability of the later, as previously confirmed by SEM-EDS (Figure 4). In all glass samples,
the blue-shift of the most intense peak at ~1030 cm´1 to 1045–1055 cm´1 after one day soaking in
SBF solution is characteristic of both P–O stretching vibrations in hydroxyapatite in combination
with Si–O vibrations of the silica phase, confirming the fast precipitation of Ca–P species onto
the glasses surface [43]. Due to the presence of CO32´ species in its composition, the resultant
Ca–P layer can be identified as a hydroxycarbonateapatite (HCA) layer [44,45]. The delay in the
crystallization of this layer observed for the glass with higher MgO content (B32) may be related to
several issues. It is well known that both, MgO and CaO, are considered as glass modifiers, contributing
to the modification of the glass properties by increasing the number of non-bridging oxygens and
inducing the formation of Si–O–Mg–O–Si or Si–O–Ca–O–Si bonds [36]. Some authors have suggested
that the chemical durability of a glass is closely related with the thermodynamic stability of their
component oxides [46]. According to literature, the higher Gibbs free energy calculated for the ion
exchange reaction between water and a glass of binary system MgO-SiO2 (∆G˝= ´13.888 cal¨mol´1)
in comparison with the analogue determined for a CaO-SiO2 system (∆G˝ = ´16.116 cal¨mol´1) may
explain the delay in the leaching of Mg2+ to the solution, as well as in the first step of bioactivity
mechanism, resulting in a slower transformation of the calcium phosphate layer in a more stable
apatite phase [47]. Another theory that could explain this result is related with the ionic field strength
I (I = Z/r2) of Mg2+ and Ca2+, which is related with cation charge (Z) and ionic radius (r) [48]. Thus,
in this case, the higher ionic field strength of Mg2+ (4.73 Å´2) in respect to the one of Ca2+ (2.04 Å´2)
suggest that the former would contribute to the formation of tighter glass networks than the later,
due to its lower glass modifier character. Furthermore, it was already studied that, apart from being
a network modifier, MgO may be also considered as an intermediate oxide that is stored in the network
in the form of MgO4. The intercalation of this MgO4 species in the glass network contributes to
an increase in the polymerization of the glass, which in turn results in a decrease of bioactivity [35].
Although a slower crystallization kinetics of the apatite layer has been observed in glass B32,
Figure 8 suggests that the total reconstruction of the glass was totally completed after 14 days of
immersion in SBF, where a plateau around pH ~8.2–8.5 was achieved in all the samples.
The lower pH exhibited by sample B4 along all the bioactivity experiment may arise not only
from the higher amount of P2O5 in its glass composition, but also from the lower contents of network
modifier like Na2O and K2O. The higher release of phosphate species from the glasses with higher
P2O5 contents probably buffers the alkalinity resultant from the Ca2+ and Na+ release into the SBF
solution maintaining it in a lower pH [26]. Additionally, the increased propensity of Ca2+ to coordinate
the phosphate network of the glass may also contribute for this behavior. On the other hand, the
higher amount of Na2O content of B31 and B32 leads to a weaker glass network, increases the fraction
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of non-bonding oxygens and thus allows an easier ionic exchange between glass and SBF. This results
in a higher ionic exchange between the glass and SBF solution in the first stages of bioactivity and
a consequent increase in the pH of the medium. The higher amount of MgO present in glass B32 did
not have a high influence on the pH changes observed during the bioactivity experiment, apart from
a slightly lower pH observed between 3 and 14 days of immersion in SBF solution. This behavior may
arise from a decreased precipitation of acidic species (HCO3´ and HPO42´) from the SBF solution,
as a consequence of the lower apatite crystallization kinetics exhibited by this sample. The lower pH
registered for sample B4 is also translated in a lower weight loss, as observed in Figure 9.
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composition of glass B4 and its consequently lower glass solubility. The presence of MgO in the glass
B32 caused a slightly lower solubility of the same until seven days of immersion in SBF solution.
This lower glass degradability may arise not only from the higher energy of Mg–O bond, limiting
its reactivity and ion leaching, but also from the role of this oxide in glass network, that may to act
either as a glass modifier or as an intermediate oxide [35,51]. After 14 days immersion in SBF solution,
this glass presents a slightly higher solubility that may be linked with an increased kinetics of ionic
exchange between the glass and SBF solution at this stage, which is in accordance with the pH changes
observed for this same time period (Figure 9).
The mechanism by which the low Ca/P ratio in glass composition increase their bioactivity
may also involve the formation of Ca3(PO4)2 complexes in the glass network on the proximities
of the the silica gel layer and facilitate the migration of Ca2+ and PO43´ species from solution,
inducing the crystallization of a hydroxycarbonateapatite layer and a consequent increase in the
glass bioactivity [42].
3. Experimental Section
Technical grade powders of SiO2, Ca3(PO4)2, Na2CO3, KNO3, CaCO3, MgO, and CaF2 were
mixed in the required proportions to obtain glasses with nominal composition (wt %) 40.4% SiO2,
7% Na2O, 0.3% K2O, 30% CaO, 17% P2O5, 4% MgO, 1.3% CaF2 (B4); 40% SiO2, 10.5% Na2O, 0.5% K2O,
30% CaO, 14% P2O5, 3.0% MgO, 2.0% CaF2 (B31); 40% SiO2, 10.5% Na2O, 0.5% K2O, 28.0% CaO,
14% P2O5, 5.0% MgO, and 2.0% CaF2 (B32). The glasses were synthesized by melting the reactants in
a platinum crucible at 1400 ˝C for 2 h (Nannetti electric furnace, Nannetti S.r.l., Faenza, Italy), following
a quenching of the melt in water and obtaining a frit. The glass-frit was subsequently wet milled in
a high speed porcelain mill using water and Al2O3 spheres, dried at 100 ˝C and passed through a sieve
to obtain fine glass powders with dimension <64 µm.
In order to detect the characteristic temperatures of the glasses, differential scanning calorimetry
(DSC) was measured in a Netzsch STA 449C, in air atmosphere, using Pt-Rh crucibles. For this
experiment, 50 mg of the glass powders were heated from room temperature to 1350 ˝C (β = 3 ˝C¨min´1).
The parameter β corresponds to the heating rate in ˝C¨min´1.
The sintering behavior of the glasses was studied with cylindrical powder compacts with 3 mm
height and 1 mm diameter prepared by cold pressing. The samples, placed on an alumina support,
were subsequently heated in a hot stage microscope (side-view HSM Misura equipped with an image
analysis system and an electrical furnace 1750/15 Leica, Expert System Solutions S.r.l., Modena, Italy)
from room temperature to 1350 ˝C (β = 10 ˝C¨min´1) and the size and shape variations were recorded
by analyzing images taken in 10 ˝C intervals between 400 to 1350 ˝C. The temperature was measured
with a Pt/Rh (6/30) thermocouple in contact with the alumina support.
To investigate the type of crystalline phases that grow during heating in the glass matrices,
cylindrical green compacts of glass powders with diameter of 1 cm and height of 0.5 cm, prepared
by cold uniaxial pressing 750 mg of the glass powders (<64 µm) at 9 bars for 30 s, have been heated
up to the crystallization temperatures detected by DSC analysis (β = 5 ˝C¨min´1) and maintained at
temperature for 1 h.
The in vitro bioactivity of the glasses was investigated using sintered glass pellets with similar
dimensions and fabricated by a similar method: on the basis of DSC/HSM studies, the pellets were
heated at 690 ˝C (B4) or 660 ˝C (B31 and B32) for 40 or 20 min (β = 20 ˝C/min), respectively, and
subsequently sonicated in acetone for 5 min. The solubility and apatite forming ability of the pellets
were investigated by soaking them in 30 mL of simulated body fluid (SBF) at 37 ˝C, pH = 7.4. The SBF
solution had an ionic concentration (Na+ 142.0, K+ 5.0, Ca2+ 2.5, Mg2+ 1.5, Cl´ 148.8, HPO4´ 1.0,
HCO32´ 4.2, and SO42´ 0.5 mmol¨L´1) nearly equivalent to human plasma [29]. After filtering the
SBF through sterilized filters (cameo 25 AS-MSI, pore size 0.22 µm), the glass-SBF mixtures were sealed
into sterilized polyurethane flasks and placed in an incubator at 37 ˝C (˘0.5 K) for 1, 3, 7, 14 and
21 days. The experiments were performed in triplicate to assure the accuracy of results. After each
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experiment, the glass pellets were removed from the solution, rinsed extensively with distilled water
and dried at 100 ˝C for 1 h. The weight of the dried glass pellets, as well as the pH changes of the
resulting SBF solutions were registered. Structural modifications occurring on the surface of glass
samples were investigated by Fourier transform infrared spectroscopy (FTIR). For the measurements,
10 mg of the powders were loaded on the sample holder and the FTIR spectra acquired in a Cary
630 FT/IR (Agilent Technologies, Santa Clara, CA, USA) from 4000 to 400 cm´1 with 2 cm´1 resolution.
The amorphous/crystalline nature of the glass surface, as well as qualitative analysis of crystalline
phases, were determined by X-ray diffraction (XRD) analysis using a conventional Bragg-Brentano
diffractometer (PANalytical, Almelo, The Netherlands) with Cu-Kα radiation. Data were recorded
in the 2θ angle range between 3˝ and 90˝ (step size 0.02˝ and 19.7 s of counting time for each step)
and the pattern analysis was carried out using X’Pert High Score software and the PCPDF data
bank. Morphological and compositional modifications occurring on the surface of the pellets were
investigated by scanning electron microscopy (SEM, Quanta Inspect 200, FEI, Hillsboro, OR, USA)
with energy dispersive spectroscopy (EDS, model EDAX PV9900, EDAX Inc., Mahwah, NJ, USA).
The analysis was done on Au sputtered samples and the pictures acquired at 15.0 kV.
4. Conclusions
The synthesis of new glasses with low Ca/P ratio and high bioactivity was successfully achieved.
Furthermore, the synthesized glasses also presented a good thermal behavior, reflected by their high
sintering ability. The synthesis of these new glass formulations may contribute to a change in the
initial strategy for designing bioactive glasses, which has been extensively based on the theory that the
highest bioactivity is achieved for glasses having low P2O5 (~6 wt %) amount in their composition.
These results are expected to open new insights on the design of new glasses with enhanced properties
for biomedical applications.
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